When was PharmaLex founded?

PharmaLex was founded in 1998 and raised its 1st funding round 21 years after it was founded.

Where is PharmaLex located?

PharmaLex is headquartered in Mannheim, Germany. It is registered at 24, Agern Alle, Hørsholm, 2970.

Who is the current CEO of PharmaLex?

Thomas Dobmeyer and Tilo Netzer s of PharmaLex. Thomas Dobmeyer is also an angel investors in 1 startup.

Which legal entities is PharmaLex associated with?

PharmaLex is associated with PharmaLex Holding GmbH and 6 others.

How many employees does PharmaLex have?

As of Mar 31, 2026, the latest employee count at PharmaLex is 1814.

Is PharmaLex a funded company?

PharmaLex is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Jan 01, 2019.

When was the latest funding round of PharmaLex?

PharmaLex's latest funding was a $***** Grant (prize money) round on Jun 01, 2022, with participation from 1 investor.

Where does PharmaLex rank among its competitors?

PharmaLex ranks 18th amongst 1709 active competitors, of which 27 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of PharmaLex?

PharmaLex's top competitors include Indegene, IntegriChain and Prescient Healthcare Group. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

PharmaLex - 2026 Company Profile, Team, Funding, Competitors & Financials

Q: Is PharmaLex an acquired company?

PharmaLex got acquired by AmerisourceBergen on Sep 12, 2022.

Company Details

PharmaLex is a CRO specializing in development consulting, scientific and regulatory affairs, and pharmacovigilance. The current corporate entity was formed in 2015 following the merger of YES Pharma and PharmaLex. The company's services include scientific affairs (development strategy and gap analysis, clinical trial design, health authority briefing documents, scientific advice, due diligence, CTD clinical and non-clinical documents, PIP/PIP waiver, pediatric study plans, environmental risk assessment), regulatory affairs (procedure management/ health authority contact, electronic submission services, change control procedures, CMC writing, CCDS development and worldwide rollout, full maintenance service, line extensions and referrals), and pharmacovigilance (risk management, signal management, periodic safety reports, pharmacovigilance system and compliance, EU-QPPV/ local QPPV, quality system, audit and inspection support, safety data exchange agreements, ICSR management, including collection, evaluation, processing, distribution and reporting.

Website: www.pharmalex.com/
Social
Email ID: *****@pharmalex.com
Phone Number: +49 **********
Part Of
Registered Address: 24, Agern Alle, Hørsholm, 2970

Key Metrics

Founded Year

1998

Location

Mannheim, Germany

Stage

Acquired

Latest Funding Round

Grant (prize money), Jun 01, 2022, $*****

Investors

Sahlgrenska Science Park & 7 more

Ranked

18^th among 1709 active competitors

Employee Count

1,814 as on Mar 31, 2026

Investment & Acquisitions

DRA & 4 more

Similar Companies

ProPharma Group & 437 more

Exit Details

Acquired by AmerisourceBergen (Sep 12, 2022)

View PharmaLex's full profile

PharmaLex is associated with 7 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PharmaLex Holding GmbH CIN: HRB13021 , Germany, Active	Aug 25, 2014	-	1025 (As on Dec 31, 2020)
Pharmalex GmbH CIN: 699586 , Switzerland, Active	Aug 26, 2021	-	-	-
PharmaLex GmbH CIN: HRB13017 , Germany, Active	Aug 25, 2014	-	280 (As on Dec 31, 2021)
PharmaLex Denmark A/S CIN: 18652439 , Denmark, Active	Jun 30, 1995	-	-
PHARMALEX NORWAY AS CIN: 887079862 , Norway, Active	Jul 03, 2004	-	13 (As on Dec 31, 2023)
PHARMALEX INDIA PRIVATE LIMITED CIN: U85100DL2013FTC252553 , India, Active	May 23, 2013	$8.84M (As on Mar 31, 2025)	310 (As on Oct 31, 2024)
Pharmalex Nordic ApS CIN: 37541540 , Denmark, Active	Mar 15, 2016	-	-

PharmaLex got acquired by AmerisourceBergen on Sep 12, 2022 at an acquisition amount of $*****.

Click here to take a look at PharmaLex's acquisition in detail

PharmaLex has raised funding over 2 rounds. Its first funding round was on Jan 01, 2019. Its latest funding round was a Grant (prize money) round on Jun 01, 2022 for $*****. 1 investor participated in its latest round. PharmaLex has 5 institutional investors and 3 angel investors.

Here is the list of recent funding rounds of PharmaLex:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jun 01, 2022	4479624	Grant (prize money)	3142251	9387496	9779607	7437396
Jan 01, 2019	9028931	Grant (prize money)	7441443	5145764	8522314	Europa

Access funding benchmarks and valuations. Sign up today!

View details of PharmaLex's funding rounds and investors

PharmaLex's employee count trend

PharmaLex has 1,814 employees as of Mar 26. Here is PharmaLex's employee count trend over the years:

Uncover PharmaLex's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PharmaLex include Indegene, IntegriChain and Prescient Healthcare Group. Here is the list of Top 10 competitors of PharmaLex, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	76/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	63/100
3rd	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Intertrust, Bridgepoint Group & 8 others	61/100
4th	ProPharma Group 2001, Saint Paul (United States), Acquired	Provider of regulatory compliance solutions to pharmaceutical, biotechnology and medical device	-	Apollo Investment Corporation, Jump Capital ... & 3 others	61/100
5th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, HSBC & 3 others	59/100
6th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	58/100
7th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
8th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	56/100
9th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	55/100
10th	Alacrita 2009, Waltham (United States), Unfunded	Pharma & biotech consulting: R&D, business support, and expert solutions	-	-	52/100
18th	PharmaLex 1998, Mannheim (Germany), Acquired	CRO specializing in regulatory affairs and pharmacovigilance	-	Sahlgrenska Science Park, View Beyong Partners ... & 6 others	47/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on PharmaLex's competitors? Click here to see the top ones

PharmaLex has not made any investments yet. PharmaLex has made 5 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Aug 26, 2022	Acquisition	DRA	2002	Vantaa (Finland)
Mar 03, 2021	Acquisition	ERA Consulting	1987	London (United Kingdom)
Apr 24, 2017	Acquisition	The Degge Group	1988	Fairfax (United States)